Conference Coverage

Optimal epilepsy care extends well beyond managing seizures


 

From AES 2021

‘Drift down hypothesis’

Commenting on the findings, Fred A. Lado, MD, PhD, director of epilepsy at Northwell Health Eastern and Central Regions, said the increased incidence of comorbidities in patients of low socioeconomic status was not surprising.

“The interesting data here is that we see an even higher incidence among people with epilepsy,” said Dr. Lado, who was not involved with the research.

The study shows how epilepsy exacerbates the effects of low socioeconomic status, he added.

“One of the determinants of socioeconomic status in this case may well be the fact they have seizures and have a limited ability to work and are often more dependent on state assistance and disability support,” Dr. Lado said.

He also referred to the “drift down hypothesis” of chronic disease. “If you have epilepsy and are born into a middle-class family, chances are you will be on disability and can’t work, so you probably have a lower socioeconomic status than your family did as you grew up.”

Dr. Lado noted how “extremely common” mood disorders are in this population and that certain pain syndromes “tracked with those mood disorders.”

“We know mood disorders are more prevalent in people with epilepsy, and now we see that pain-related problems – headache and back pain – are more prevalent in people with epilepsy,” he said.

The data showing “downstream effects of the mood disorders,” from epilepsy to mood disorders to pain disorders, was “very interesting,” Dr. Lado said.

The study was funded by the Centers for Disease Control and Prevention and the National Institute on Minority Health and Health Disparities of the National Institutes of Health. Mr. Bensken has reported receiving research support for this work from the NIH.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Can a supplement that mimics the keto diet reduce seizures?
Epilepsy Resource Center
Short-term approach is best for seizure prevention after intracerebral hemorrhage
Epilepsy Resource Center
‘No justification’ for suicide warning on all antiseizure meds
Epilepsy Resource Center
FDA OKs IV Briviact for seizures in kids as young as 1 month
Epilepsy Resource Center
Data supporting cannabis for childhood epilepsy remain scarce
Epilepsy Resource Center
Is genetic testing valuable in the clinical management of epilepsy?
Epilepsy Resource Center
Double antiglutamatergic therapy is ‘promising’ for super-refractory status epilepticus
Epilepsy Resource Center
Epidiolex plus THC lowers seizures in pediatric epilepsy
Epilepsy Resource Center
Managing simple febrile seizures without lumbar puncture safe: 15-year study
Epilepsy Resource Center
Hypertension may double the risk of late-onset epilepsy
Epilepsy Resource Center